
Hidden Sensors Reveal Filthy Truth About Handwashing in Hospital Bathrooms
Scientists from the University of Surrey in England led the study, installing sensors near hospital toilet and sink pipes to keep track of people's handwashing. Nearly half of toilet users skipped the sink after flushing, they found. The researchers say more effective strategies are needed to remind and convince people of the importance of handwashing, particularly in high-risk environments like hospitals.
Scientists Capture the Spray From a Flushing Toilet in All Its Disgusting Glory
Previous studies have tried to analyze how rigorous people are about handwashing in hospitals and other settings, but they've been limited. Some have relied on asking people to self-report their hygiene habits, for instance, which might incentivize more than a few to fudge the truth. The researchers decided to take a different approach. They connected sensors to toilet and sink pipes that could objectively and non-intrusively detect if and when they were being used. The sensors work by measuring the temperature in the pipes and nearby air; when either cold or hot water passes through the pipes, the temperature sharply changes relative to its surroundings, indicating use.
The researchers teamed up with the Bispebjerg Hospital in Denmark to conduct their study (aptly named the 'FLUSH. WASH. PROTECT.' study). For 19 weeks, they tracked people's handwashing behaviors at two public restrooms in the hospital, ultimately recording more than 2,600 flushes. Nearly 44% of the time after flushing, people steered clear of handwashing. At times, non-adherence was even worse, with over 60% of people not handwashing during certain weeks. Non-handwashing was also more common at the start and end of the day and during typical meal times. The team released its findings last week on the Open Source Framework.
'People may assume handwashing is second nature by now—especially in hospitals and post-covid-19—but our data paints a different picture,' said lead author Pablo Pereira-Doel, co-leader of the Human Insight Lab at the University of Surrey's Business School, in a statement from the university.
Mosquitoes Have Mixed Feelings About Soap, Study Finds
Low rates of handwashing can, of course, make it easier for doctors, patients, and visitors to inadvertently spread dangerous infections to already vulnerable people, including drug-resistant superbugs. Some studies have suggested that certain interventions, like clear signs, can modestly boost handwashing at hospitals, at least temporarily. But given the results here, it's likely we'll need to do a lot more to consistently improve people's hand hygiene.
'These findings are worrying but not surprising. Even simple behaviors like handwashing can lapse without reinforcement. In hospitals, lapses like these can have serious consequences—for patients and for the wider healthcare system. It's time we moved beyond posters and hand gel stations to more effective behavioral strategies,' said study author Carrie Newlands, Lead for Clinical Skills at the University of Surrey's School of Medicine, in a statement.
In the meantime, I wouldn't blame you (or myself) for avoiding the standard handshake more often. And just in case anyone needs it, here's the proper technique for handwashing, courtesy of the Centers for Disease Control and Prevention.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
38 minutes ago
- Bloomberg
Roche to Test Whether New Drug Can Prevent Alzheimer's Disease
Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high-risk people, its latest investment in one of the most failure-prone areas of drugmaking. The new late-stage study will focus on people who are at risk of cognitive decline, Roche said in a statement late Sunday. The goal would be to slow down the emergence of symptoms, or prevent them entirely.
Yahoo
2 hours ago
- Yahoo
Human Babies Aren't Supposed to Have 3 Parents—but Now They Can
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Here's what you'll learn when you read this story: The first babies with three biological parents were born out of a new technique to prevent mitochondrial disease. The nucleus of an egg fertilized in vitro was transferred into a donor egg without a nucleus, but with viable mitochondria. Eight healthy babies, including a set of twins, were born with low to undetectable levels of mitochondrial mutations. The only creatures known to conceive offspring from more than two parents are salamanders. Females from the genus Ambystoma (which are notoriously promiscuous) mate with up to three different males, and that DNA is then incorporated into what is known as a triploid genome in their offspring. Now a version of this has become possible in humans. It seems limb regeneration isn't the only way medical intervention can put humans on salamanders' level. Being born with three genomes is not a phenomenon that occurs naturally in Homo sapiens, but in an attempt to prevent certain genetic conditions caused by mutations in the mitochondria, scientists have found a way. Mitochondrial DNA or mtDNA is exclusively passed down from the maternal side. Dysfunction in the mitochondria can lead to metabolic diseases characterized by symptoms such as seizures, developmental delays, blindness, and loss of muscular function. Some can even be fatal. Mitochondrial diseases occur in about 1 in every 5,000 people. They were previously only preventable by using a donor egg or foregoing the conception of biological children altogether. This is why pediatric neurologist Bobby McFarland, of Newcastle University in the UK, led an experimental study that would reduce and potentially eliminate the risk of mitochondrial disease with a new method of in vitro fertilization. McFarland and his research team wanted see if removing the nucleus of an egg and placing it in a donor egg with viable mitochondria would result in healthy offspring. 'We found that pronuclear transfer, a form of mitochondrial donation, was effective in reducing the level of pathogenic mtDNA variant to substantially below the threshold for clinical disease in the offspring of women with homoplasmic (or high heteroplasmic) levels,' he said in a study recently published in the New England Journal of Medicine. When mitochondria are homoplasmic, all copies produced by cell division have mutations. Mutation levels vary in heteroplasmic mitochondria. Preimplantation genetic testing (PGT) can screen for these abonormalities, and women with homoplasmy or high levels of heteroplasmy can benefit from what is now known as pronuclear transfer. This involves eggs from both the mother and donor being fertilized with the father's sperm in vitro. Nuclei are then removed from both eggs after ten hours. Since the nucleus carries most genetic material and has no connection to mitochondrial disease, the mother's nucleus is implanted into the donor egg to take advantage of its mitochondria. While there is a chance that a few of the mother's mitochondria may end up in the embryo, it is unlikely to cause a debilitating disease. Levels of defective mitochondria in offspring conceived via pronuclear transfer were low enough to escape that fate. Eight pregnancies (including a set of twins) resulted from the experiment, and while there were a few minor health problems in the newborns, these were either treatable or corrected themselves. Not only were levels of heteroplasty low for the babies, but undetectable in five of them. Developmental progress also turned out to be normal. Though one baby had a form of infant epilepsy, and another had heart arrhythmia and hyperlipidemia, or high levels of fats and lipids in the blood, both of these conditions were treated and resolved. Whether the hyperlipidemia was even caused by mtDNA is uncertain, especially because the mother also had severe hyperlipidemia during her pregnancy. Though there was a chance that any of the mothers with pathogenic mtDNA had a higher risk of complications during pregnancy, which could possibly cause their children to have health issues, there is no proof for now. 'We are assessing, over the long term, the health and extent of heteroplasmy (if detectable) of the offspring,' McFarland and his team said. 'Indeed, the role of mitochondrial donation as a choice for women with a heritable pathogenic mtDNA variant will only be established with the availability of additional data.' You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50 Solve the daily Crossword
Yahoo
3 hours ago
- Yahoo
Merck (MRK) as a Reliable Dividend Player in the Dogs of the Dow Lineup
Merck & Co., Inc. (NYSE:MRK) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. A close-up of a person's hand holding a bottle of pharmaceuticals. Merck & Co., Inc. (NYSE:MRK) has faced stock pressure due to its reliance on Keytruda but is diversifying. On July 9, Merck announced it would acquire UK biotech Verona Pharma for $10 billion, adding Ohtuvayre, a promising COPD treatment approved last year, to its portfolio. Ohtuvayre has had a strong launch and is being studied for more uses. Some analysts predict its sales could reach $4 billion, potentially making it another blockbuster for Merck. In its first quarter earnings, Merck & Co., Inc. (NYSE:MRK) highlighted that it began the year with strong progress, driven by growing contributions from its recently commercialized medicines and vaccines, along with ongoing advancements in its pipeline. It is focused and determined to fully capitalize on near-term opportunities while swiftly advancing the next wave of innovations that will improve patient outcomes and create long-term value for all stakeholders. Merck & Co., Inc. (NYSE:MRK) is also popular because of its dividend growth history, which spans 16 consecutive years. Currently, the company offers a quarterly dividend of $0.81 per share and has a dividend yield of 3.82%, as of July 26. While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten